Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid.

Martinsen TC, Fossmark R, Waldum HL.

Int J Mol Sci. 2019 Nov 29;20(23). pii: E6031. doi: 10.3390/ijms20236031. Review.

2.

Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility.

Fossmark R, Martinsen TC, Waldum HL.

Int J Mol Sci. 2019 Oct 21;20(20). pii: E5203. doi: 10.3390/ijms20205203. Review.

3.

Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.

Waldum HL, Rehfeld JF.

Scand J Gastroenterol. 2019 Sep;54(9):1118-1123. doi: 10.1080/00365521.2019.1663446. Epub 2019 Sep 14.

PMID:
31524029
4.

Role of Autoimmune Gastritis in Gastric Cancer.

Waldum HL, Fossmark R.

Clin Transl Gastroenterol. 2019 Sep;10(9):e00080. doi: 10.14309/ctg.0000000000000080. No abstract available.

5.

Hepatic micrometastases outside macrometastases are present in all patients with ileal neuroendocrine primary tumour at the time of liver resection.

Fossmark R, Balto TM, Martinsen TC, Grønbech JE, Munkvold B, Mjønes PG, Waldum HL.

Scand J Gastroenterol. 2019 Aug;54(8):1003-1007. doi: 10.1080/00365521.2019.1647281. Epub 2019 Aug 1.

PMID:
31368380
6.

The Enterochromaffin-like [ECL] Cell-Central in Gastric Physiology and Pathology.

Waldum HL, Sørdal ØF, Mjønes PG.

Int J Mol Sci. 2019 May 17;20(10). pii: E2444. doi: 10.3390/ijms20102444. Review.

7.

Types of Gastric Carcinomas.

Waldum HL, Fossmark R.

Int J Mol Sci. 2018 Dec 18;19(12). pii: E4109. doi: 10.3390/ijms19124109. Review.

8.

Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift.

Waldum HL, Öberg K, Sørdal ØF, Sandvik AK, Gustafsson BI, Mjønes P, Fossmark R.

Therap Adv Gastroenterol. 2018 May 27;11:1756284818775054. doi: 10.1177/1756284818775054. eCollection 2018. Review.

9.

Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.

Waldum HL, Sørdal Ø, Fossmark R.

Scand J Gastroenterol. 2018 Jun;53(6):639-642. doi: 10.1080/00365521.2018.1450442. Epub 2018 May 31. Review.

PMID:
29852782
10.

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.

Mjønes P, Nordrum IS, Sørdal Ø, Sagatun L, Fossmark R, Sandvik A, Waldum HL.

Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.

11.

Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.

Mjønes P, Sagatun L, Nordrum IS, Waldum HL.

J Histochem Cytochem. 2017 Dec;65(12):687-703. doi: 10.1369/0022155417733676. Epub 2017 Oct 3.

12.

The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.

Vange P, Bruland T, Doseth B, Fossmark R, Sousa MML, Beisvag V, Sørdal Ø, Qvigstad G, Waldum HL, Sandvik AK, Bakke I.

PLoS One. 2017 Sep 13;12(9):e0184514. doi: 10.1371/journal.pone.0184514. eCollection 2017.

13.

Chronic cholestatic liver diseases.

Waldum HL, Björnsson ES, Brenna E.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):788. doi: 10.1080/00365521.2017.1296276. Epub 2017 Feb 28. No abstract available.

PMID:
28276829
14.

Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma.

Mjønes PG, Nordrum IS, Qvigstad G, Sørdal Ø, Rian LL, Waldum HL.

APMIS. 2017 Mar;125(3):213-222. doi: 10.1111/apm.12654.

PMID:
28233444
15.

Gastrin and Gastric Cancer.

Waldum HL, Sagatun L, Mjønes P.

Front Endocrinol (Lausanne). 2017 Jan 17;8:1. doi: 10.3389/fendo.2017.00001. eCollection 2017. Review.

16.

Helicobacter pylori and gastric acid: an intimate and reciprocal relationship.

Waldum HL, Kleveland PM, Sørdal ØF.

Therap Adv Gastroenterol. 2016 Nov;9(6):836-844. Epub 2016 Aug 23. Review.

17.

Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.

Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F, Fossmark R, Waldum HL, Pritchard DM.

Br J Clin Pharmacol. 2017 Mar;83(3):466-475. doi: 10.1111/bcp.13146. Epub 2016 Nov 21.

18.

Proton Pump Inhibitors and Dementia Incidence.

Waldum HL, Martinsen TC.

JAMA Neurol. 2016 Aug 1;73(8):1026. doi: 10.1001/jamaneurol.2016.1497. No abstract available.

PMID:
27322028
19.

Follow-up of patients with ECL cell-derived tumours.

Sagatun L, Fossmark R, Jianu CS, Qvigstad G, Nordrum IS, Mjønes P, Waldum HL.

Scand J Gastroenterol. 2016 Nov;51(11):1398-405. doi: 10.3109/00365521.2016.1169588. Epub 2016 Jun 16.

PMID:
27309188
20.

ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit.

Fossmark R, Calvete O, Mjønes P, Benitez J, Waldum HL.

APMIS. 2016 Jul;124(7):561-6. doi: 10.1111/apm.12546. Epub 2016 May 6.

PMID:
27150581

Supplemental Content

Loading ...
Support Center